IIA
SLDB icon

IPG Investment Advisors’s Solid Biosciences SLDB Stock Holding History

IPG Investment Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,193
Closed -$8.35K – 155
2022
Q3 		$8.35K Hold
1,193
– – ﹤0.01% 141
2022
Q2 		$11K Hold
1,193
– – ﹤0.01% 157
2022
Q1 		$21K Hold
1,193
– – ﹤0.01% 166
2021
Q4 		$32K Hold
1,193
– – 0.01% 201
2021
Q3 		$42.8K Buy
+1,193
New +$50.7K 0.01% 127

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IPG Investment Advisors's SLDB Position: Q4 2022 in Review

IPG Investment Advisors sold out of Solid Biosciences (SLDB) in Q4 2022, closing a stake of 1,193 shares — an estimated $8.35K sold.

IPG Investment Advisors first reported a position in SLDB in Q3 2021 and held it in 5 quarters. The position peaked at $42.8K in Q3 2021. 35 funds tracked by Wall St. Rank hold SLDB as of Q4 2022.

  • IPG Investment Advisors reported no remaining Solid Biosciences position as of Q4 2022 after selling out during the quarter.
  • IPG Investment Advisors sold 1,193 Solid Biosciences shares in Q4 2022, an estimated $8.35K.
  • IPG Investment Advisors first reported a position in Solid Biosciences in Q3 2021 and held it in 5 quarters.
  • IPG Investment Advisors's Solid Biosciences position peaked at $42.8K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2022.

Based on IPG Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.